Nucleoid Pharmaceutical Private Limited
About Nucleoid Pharmaceutical Private Limited
Data last updated:
Nucleoid Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC347425. Its GSTIN is 09AAGCN4563J1Z2 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hariom and Ashish Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. B – 10 F/F Kh2/23 Block – B Mansa Ram Park Uttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.75 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net loss of ₹2.34 Lakh (net margin -14.8%) and EBITDA of -₹1.47 Lakh (EBITDA margin -9.3%). Revenue has grown at a compounded annual rate (CAGR) of 176% over three years.
Court records list 1 case involving the company, including 1 filed against it.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. B – 10 F/F Kh2/23 Block – B Mansa Ram Park Uttam Nagar, Delhi, India – 110059
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nucleoid Pharmaceutical Private Limited
The main business activity of Nucleoid Pharmaceutical is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nucleoid Pharmaceutical Private Limited FY 2025 filings available
Nucleoid Pharmaceutical Private Limited reported revenue of ₹15.75 Lakh (up 40% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Nucleoid Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 176% over three years, including 40% growth in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nucleoid Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.47 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.34 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nucleoid Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -14.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nucleoid Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nucleoid Pharmaceutical Private Limited
Nucleoid Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hariom | Director | 19 Mar 2019 | 7 Years 6 Months | Current |
| Ashish Verma | Director | 19 Mar 2019 | 7 Years 6 Months | Current |
Charges & Borrowings of Nucleoid Pharmaceutical Private Limited
Nucleoid Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Nucleoid Pharmaceutical Private Limited
Nucleoid Pharmaceutical Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Mankind Pharma Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Nucleoid Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Nucleoid Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nucleoid Pharmaceutical Private Limited
Nucleoid Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ashish Verma was appointed as Director on 19 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Nucleoid Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nucleoid Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nucleoid Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nucleoid Pharmaceutical Private Limited
Nucleoid Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCN4563J1Z2 | Uttar Pradesh | Active | 15 Jul 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nucleoid Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nucleoid Pharmaceutical Private Limited
Nucleoid Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 March 2019 (7+ years old) and is registered under CIN U51909DL2019PTC347425.
Nucleoid Pharmaceutical reported revenue of ₹15.75 Lakh for FY 2024 (up 40% YoY).
Nucleoid Pharmaceutical has 2 current directors:
- Hariom - Director
- Ashish Verma - Director
Nucleoid Pharmaceutical reported a net loss of ₹2.34 Lakh (net margin -14.8%) and EBITDA of -₹1.47 Lakh (EBITDA margin -9.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nucleoid Pharmaceutical is 176% over three years. In the latest year (FY 2024) revenue rose 40%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nucleoid Pharmaceutical is 09AAGCN4563J1Z2, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nucleoid Pharmaceutical is U51909DL2019PTC347425. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nucleoid Pharmaceutical has 1 court case on record: 1 filed against it.
Nucleoid Pharmaceutical was incorporated on 19 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Ashish Verma was appointed as Director on 19 Mar 2019. Hariom was appointed as Director on 19 Mar 2019.